Paul A. Price

Q: What Schools Are Affiliated With Paul A. Price

Paul A. Price is affiliated with the following schools: Aarhus University, Eastern Michigan University, University of California, San Diego, University of Algarve, Pennsylvania State University, University of Copenhagen, University of North Carolina at Chapel Hill, Brigham Young University

Paul A. Price's AcademicInfluence.com Rankings

Paul A. Price

Biology

#7543

World Rank

#10482

Historical Rank

Biochemistry

#1043

World Rank

#1157

Historical Rank

biology Degrees

Download Badge

Biology

Paul A. Price's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Chemistry Stanford University

Why Is Paul A. Price Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paul A. Price's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Characterization of a gamma-carboxyglutamic acid-containing protein from bone. (1976) (698)
New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. (1980) (674)
Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. (1998) (545)
Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. (1981) (489)
1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. (1980) (453)
Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. (1980) (433)
Osteoprotegerin Inhibits Artery Calcification Induced by Warfarin and by Vitamin D (2001) (381)
Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. (1983) (350)
Bisphosphonates Alendronate and Ibandronate Inhibit Artery Calcification at Doses Comparable to Those That Inhibit Bone Resorption (2001) (307)
Serum YKL-40, A New Prognostic Biomarker in Cancer Patients? (2006) (293)
A Plasminogen-Activating Protease Specifically Controls the Development of Primary Pneumonic Plague (2007) (278)
YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. (1998) (265)
Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. (1985) (263)
Serum YKL-40 is increased in patients with hepatic fibrosis. (2000) (261)
Identification of proteins secreted by human osteoblastic cells in culture (1992) (259)
Warfarin-induced artery calcification is accelerated by growth and vitamin D. (2000) (245)
A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. (1993) (240)
Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function. (1985) (240)
Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. (1980) (237)
Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. (1982) (232)
Vitamin K supplementation and progression of coronary artery calcium in older men and women. (2009) (227)
A method for decarboxylation of gamma-carboxyglutamic acid in proteins. Properties of the decarboxylated gamma-carboxyglutamic acid protein from calf bone. (1979) (227)
Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein. Implications for the possible functions of matrix Gla protein and for the tissue distribution of the gamma-carboxylase. (1988) (217)
Isolation and Sequence of a Novel Human Chondrocyte Protein Related to Mammalian Members of the Chitinase Protein Family* (1996) (206)
The Size Exclusion Characteristics of Type I Collagen (2007) (201)
The Inhibition of Calcium Phosphate Precipitation by Fetuin Is Accompanied by the Formation of a Fetuin-Mineral Complex* (2003) (197)
Disaggregation of bone into crystals (1986) (196)
High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. (2003) (194)
Serum YKL-40 and colorectal cancer (1999) (189)
Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone. (1988) (186)
Discovery of a High Molecular Weight Complex of Calcium, Phosphate, Fetuin, and Matrix γ-Carboxyglutamic Acid Protein in the Serum of Etidronate-treated Rats* (2002) (183)
Role of vitamin-K-dependent proteins in bone metabolism. (1988) (183)
Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. (1976) (183)
Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. (1999) (182)
Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. (2001) (180)
Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. (1996) (175)
The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. (1985) (172)
Secretion of the vitamin K-dependent protein of bone by rat osteosarcoma cells. Evidence for an intracellular precursor. (1980) (167)
Gla-containing proteins of bone. (1989) (166)
Effects of warfarin on bone. Studies on the vitamin K-dependent protein of rat bone. (1981) (163)
Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. (1984) (160)
The identification of matrix Gla protein in cartilage. (1988) (159)
1,25-dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone protein. (1981) (150)
Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. (1995) (147)
Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. (2003) (147)
Systematic analysis of cyclic di‐GMP signalling enzymes and their role in biofilm formation and virulence in Yersinia pestis (2011) (145)
Bone gla protein (osteocalcin) assay standardization report (1990) (145)
Molecular cloning of matrix Gla protein: implications for substrate recognition by the vitamin K-dependent gamma-carboxylase. (1987) (145)
Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. (2006) (141)
High serum YKL‐40 level after surgery for colorectal carcinoma is related to short survival (2002) (139)
Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. (2003) (138)
Developmental appearance of the vitamin K-dependent protein of bone during calcification. Analysis of mineralizing tissues in human, calf, and rat. (1981) (134)
High serum YKL-40 level in patients with small cell lung cancer is related to early death. (2004) (134)
1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines. (1988) (131)
Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene. (1990) (130)
High Serum YKL-40 Levels in Patients with Primary Breast Cancer is Related to Short Recurrence Free Survival (2003) (129)
The role of bone cells in increasing metaphyseal hard tissue in rapidly growing rats treated with prostaglandin E2. (1987) (129)
YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. (1999) (122)
Biochemical Characterization of the Serum Fetuin-Mineral Complex* (2003) (120)
Gla-rich Protein (GRP), A New Vitamin K-dependent Protein Identified from Sturgeon Cartilage and Highly Conserved in Vertebrates* (2008) (117)
Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? (1997) (117)
Minerals Form a Continuum Phase in Mature Cancellous Bone (2011) (115)
Serum Levels of the Fetuin-Mineral Complex Correlate with Artery Calcification in the Rat* (2004) (115)
Proof that the gamma-carboxyglutamic acid-containing bone protein is synthesized in calf bone. Comparative synthesis rate and effect of coumadin on synthesis. (1979) (111)
Developmental appearance of matrix GLA protein during calcification in the rat. (1986) (110)
Properties of chromatographically purified bovine pancreatic deoxyribonuclease. (1969) (110)
YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Purulent Meningitis (2002) (108)
The effects of prostaglandin E2 in rapidly growing rats: depressed longitudinal and radial growth and increased metaphyseal hard tissue mass. (1985) (107)
Mineralization by Inhibitor Exclusion (2009) (105)
Serum Level of YKL-40 is Elevated in Patients with Streptococcus pneumoniae Bacteremia and is Associated with the Outcome of the Disease (2002) (104)
The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. (2001) (104)
Prognostic value of PINP, bone alkaline phosphatase, CTX‐I, and YKL‐40 in patients with metastatic prostate carcinoma (2006) (103)
Absence of the vitamin K-dependent bone protein in fetal rat mineral. Evidence for another gamma-carboxyglutamic acid-containing component in bone. (1980) (101)
Conserved phosphorylation of serines in the Ser‐X‐Glu/Ser(P) sequences of the vitamin K‐dependent matrix Gla protein from shark, lamb, rat, cow, and human (1994) (95)
YKL-40 Protein Expression in the Early Developing Human Musculoskeletal System (2007) (94)
High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival. (2003) (92)
Direct demonstration that the vitamin k‐dependent bone gla protein is incompletely γ‐carboxylated in humans (1994) (92)
Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity? (2005) (91)
Serum levels of YKL-40 increases in patients with acute myocardial infarction (2008) (89)
YKL-40 in giant cells and macrophages from patients with giant cell arteritis. (1999) (89)
Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications. (2009) (87)
Plasma YKL‐40, as a prognostic tumor marker in recurrent ovarian cancer (2003) (87)
Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. (2009) (87)
Regulation of YKL-40 production by human articular chondrocytes. (2001) (85)
Rhizobial peptidase HrrP cleaves host-encoded signaling peptides and mediates symbiotic compatibility (2015) (83)
Microsymbiont discrimination mediated by a host-secreted peptide in Medicago truncatula (2017) (83)
Vitamin K counteracts the effect of warfarin in liver but not in bone. (1987) (83)
Early Host Cell Targets of Yersinia pestis during Primary Pneumonic Plague (2013) (81)
Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells. (1986) (80)
The distribution of YKL-40 in osteoarthritic and normal human articular cartilage. (1999) (80)
Bone Origin of the Serum Complex of Calcium, Phosphate, Fetuin, and Matrix Gla Protein: Biochemical Evidence for the Cancellous Bone‐Remodeling Compartment (2002) (79)
The essential role of Ca2+ in the activity of bovine pancreatic deoxyribonuclease. (1975) (76)
Effect of divalent cations on the reduction and re-formation of the disulfide bonds of deoxyribonuclease. (1969) (74)
High serum levels of YKL‐40 in patients with systemic sclerosis are associated with pulmonary involvement (2005) (74)
Matrix Gla Protein Is Associated With Risk Factors for Atherosclerosis but not With Coronary Artery Calcification (2006) (73)
YKL-40 tissue expression and plasma levels in patients with ovarian cancer (2009) (72)
The Elastic Lamellae of Devitalized Arteries Calcify When Incubated in Serum: Evidence for a Serum Calcification Factor (2006) (67)
Retinoic acid induces matrix Gla protein gene expression in human cells. (1992) (67)
Identification of Peptide Fragments Generated by Digestion of Bovine and Human Osteocalcin with the Lysosomal Proteinases Cathepsin B, D, L, H, and S (1997) (63)
Plasma YKL-40 and total and disease-specific mortality in the general population. (2010) (62)
Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation (2012) (62)
Ligand-dependent regulation of the 1,25-dihydroxyvitamin D3 receptor in rat osteosarcoma cells. (1987) (59)
Changes of Biochemical Markers of Bone Turnover and YKL-40 Following Hormonal Treatment for Metastatic Prostate Cancer Are Related to Survival (2007) (58)
Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. (2009) (57)
The Essential Role of Fetuin in the Serum-Induced Calcification of Collagen (2008) (55)
The effect of transcriptional inhibitors on the bone gamma-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells. (1984) (55)
YKL-40 protein expression in normal adult human tissues – an immunohistochemical study (2007) (54)
Characterization of Ca ++ and Mg ++ binding to bovine pancreatic deoxyribonuclease A. (1972) (54)
Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction. (2001) (53)
Carboxyl-terminal proteolytic processing of matrix Gla protein. (1991) (52)
Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene. (1997) (52)
Is YKL-40 a new therapeutic target in cancer? (2007) (51)
High serum levels of YKL‐40 in patients with squamous cell carcinoma of the head and neck are associated with short survival (2008) (49)
The Dependence of the Yersinia pestis Capsule on Pathogenesis Is Influenced by the Mouse Background (2010) (49)
Vitamin K-dependent carboxylase: utilization of decarboxylated bone Gla protein and matrix Gla protein as substrates. (1991) (49)
Tissue-nonspecific Alkaline Phosphatase Is Required for the Calcification of Collagen in Serum (2009) (49)
The vitamin K-dependent bone protein is accumulated within cultured osteosarcoma cells in the presence of the vitamin K antagonist warfarin. (1985) (47)
Stability of YKL-40 concentration in blood samples. (2000) (47)
Isolation and Molecular Cloning of a Novel Bone Phosphoprotein Related in Sequence to the Cystatin Family of Thiol Protease Inhibitors (*) (1995) (47)
Exfoliation syndrome: Clinical and genetic features (2001) (46)
The Amino Bisphosphonate Ibandronate Prevents Calciphylaxis in the Rat at Doses that Inhibit Bone Resorption (2002) (46)
Characterization of a new human osteosarcoma cell line OHS-4 [published erratum appears in J Cell Biol 1991 Oct;115(1):279] (1991) (45)
Characterization of a y-carboxyglutamic acid-containing protein from bone (42)
Isolation and sequence of the vitamin K‐dependent matrix Gla protein from the calcified cartilage of the soupfin shark (1994) (42)
Studies of osteocalcin function in dentin formation in rodent teeth. (1998) (41)
Purification of Matrix Gla Protein From a Marine Teleost Fish, Argyrosomus regius: Calcified Cartilage and Not Bone as the Primary Site of MGP Accumulation in Fish (2003) (41)
Sequence of the precursor to rat bone gamma-carboxyglutamic acid protein that accumulates in warfarin-treated osteosarcoma cells. (1985) (40)
SB 242784, a Selective Inhibitor of the Osteoclastic V-H+-ATPase, Inhibits Arterial Calcification in the Rat (2002) (40)
Evolution of Matrix and Bone γ-Carboxyglutamic Acid Proteins in Vertebrates* (2005) (39)
Mineralization of Decalcified Bone Occurs Under Cell Culture Conditions and Requires Bovine Serum But Not Cells (2004) (38)
Induction of matrix gla protein synthesis during prolonged 1,25-Dihydroxyvitamin D3 treatment of osteosarcoma cells (1990) (37)
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer (2008) (37)
Changes in plasma bone GLA protein during treatment of bone disease (1982) (37)
Posttranscriptional Regulation of the Yersinia pestis Cyclic AMP Receptor Protein Crp and Impact on Virulence (2014) (35)
Alkylation of a histidine residue at the active site of bovine pancreatic deoxyribonuclease. (1969) (35)
Decarboxylation of gamma-carboxyglutamic acid residues in human prothrombin. Stoichiometry of calcium binding to gamma-carboxyglutamic acid in prothrombin. (1982) (33)
[3] Analysis for γ-carboxyglutamic acid (1983) (33)
Spatially Distinct Neutrophil Responses within the Inflammatory Lesions of Pneumonic Plague (2015) (32)
Evidence for a Serum Factor That Initiates the Re-calcification of Demineralized Bone*[boxs] (2004) (32)
Disulfide cross-linking influences symbiotic activities of nodule peptide NCR247 (2016) (31)
Effect of cell density and growth factors on matrix GLA protein expression by normal rat kidney cells (1997) (31)
Direct identification of gamma-carboxyglutamic acid in the sequencing of vitamin K-dependent proteins. (1991) (30)
Alkylation of an essential histidine residue in porcine spleen deoxyribonuclease. (1973) (29)
Some effects of calcium ions on the structure of bovine pancreatic deoxyribonuclease A. (1972) (29)
Bone Gla protein messenger ribonucleic acid is regulated by both 1,25-dihydroxyvitamin D3 and 3',5'-cyclic adenosine monophosphate in rat osteosarcoma cells. (1989) (27)
Structural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic adenosine monophosphate and bone gamma-carboxyglutamic acid-containing protein from perfused rat hindquarters. (1985) (27)
Prenatal diagnosis and investigation of a fetus with chondrodysplasia punctata, ichthyosis, and Kallmann syndrome due to an Xp deletion (1992) (27)
YKL-40 Expression in Benign and Malignant Lesions of the Breast: A Methodologic Study (2007) (27)
Effect of Oral Anticoagulant Treatment on Markers for Calcium and Bone Metabolism (2000) (26)
Chemotactic response of mesenchymal cells, fibroblasts and osteoblast-like cells to bone Gla protein. (1988) (26)
Amino-acid sequence of bone Gla protein from the African clawed toad Xenopus laevis and the fish Sparus aurata. (1996) (26)
Matrix Gla protein mRNA expression in cultured type II pneumocytes. (1993) (26)
The involvement of serine and carboxyl groups in the activity of bovine pancreatic deoxyribonuclease A. (1974) (25)
Structural evidence of a fourth Gla residue in fish osteocalcin: biological implications. (2005) (24)
Fetuin‐A and BMD in Older Persons: The Health Aging and Body Composition (Health ABC) Study (2009) (24)
Validation of the bone gla protein (osteocalcin) assay (1990) (23)
Matrix Gla Protein in Xenopus laevis: Molecular Cloning, Tissue Distribution, and Evolutionary Considerations * (2001) (23)
Removal of proteases from DNase I by chromatography over agarose with covalently attached lima bean protease inhibitor. (1974) (23)
Noninvasive assessment of seasonal hormone profile in captive bald eagles (Haliaeetus leucocephalus) (1982) (22)
Concurrent warfarin treatment further reduces bone mineral levels in 1,25-dihydroxyvitamin D3-treated rats. (1983) (19)
Identification of an Osteocalcin Isoform in Fish with a Large Acidic Prodomain* (2006) (19)
Characterization of Osteocalcin (BGP) and Matrix Gla Protein (MGP) Fish Specific Antibodies: Validation for Immunodetection Studies in Lower Vertebrates (2004) (19)
Multi-site-specificity of the vitamin K-dependent carboxylase: in vitro carboxylation of des-gamma-carboxylated bone Gla protein and Des-gamma-carboxylated pro bone Gla protein. (1995) (18)
Comparison of the effects of insulin-like growth factors-I and -II on the human osteosarcoma cell line OHS-4. (1993) (18)
Substrate recognition by the vitamin k‐dependent γ‐glutamyl carboxylase: Identification of a sequence homology between the carboxylase and the carboxylase recognition site in the substrate (1993) (18)
Serum Bone γ-Carboxyglutamic Acid Protein in a Longitudinal Study of Infants: Lower Values in Formula-Fed Infants (1992) (17)
YKL-40 protein expression in normal adult human tissues – an immunohistochemical study (2007) (16)
Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients. (1986) (15)
Accumulation of the neutrophil-derived protein YKL-40 during storage of various blood components (2001) (15)
Human parotid α-amylase—A test of the error theory of aging (1974) (14)
Tiny Earth: A Big Idea for STEM Education and Antibiotic Discovery (2020) (14)
The effect of calcium and magnesium on the ultraviolet spectrum of bovine pancreatic deoxyribonuclease A. (1974) (13)
Specific tritium incorporation into gamma-carboxyglutamic acid in proteins. The pH dependence of gamma-proton exchange. (1981) (12)
Sturgeon Osteocalcin Shares Structural Features with Matrix Gla Protein (2013) (12)
A Virus in a Fungus in a Plant : Three-Way Symbiosis Required for Thermal Tolerance (2007) (11)
Inoculation with remnant prairie soils increased the growth of three native prairie legumes but not necessarily their associations with beneficial soil microbes (2020) (11)
Molecular structure of the rat bone Gla protein gene and identification of putative regulatory elements. (1989) (10)
The identification of a tryptophan residue essential to the catalytic activity of bovine pancreatic deoxyribonuclease. (1971) (10)
Some effects of calcium and magnesium ions on the activity of bovine pancreatic deoxyribonuclease A. (1975) (9)
Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls. (2006) (9)
DISCOVERY OF A HIGH MOLECULAR WEIGHT COMPLEX OF CALCIUM , PHOSPHATE , FETUIN , AND MATRIX GLA PROTEIN IN THE SERUM OF ETIDRONATE-TREATED RATS (2001) (9)
Chemical modification of gamma-carboxyglutamic acid, the vitamin K-dependent amino acid which binds Ca2+. (1984) (8)
The putative RGD-dependent cell adhesion activity of matrix Gla protein is due to higher molecular weight contaminants. (1994) (8)
A Serum Factor that Recalcifies Demineralized Bone Is Conserved in Bony Fish and Sharks but Is Not Found in Invertebrates (2006) (8)
The Effect of 1,25-Dihydroxyvitamin D 3 on the Synthesis of the Vitamin K-Dependent Protein of Bone (1984) (8)
Molecular cloning of matrix Gla protein : Implications for substrate recognition by the vitamin K-dependent y-carboxylase ( r-carboxyglutamic acid / bone / protein carboxylation ) (8)
Degradation of subcutaneous implants of bone particles from normal and warfarin‐treated rats (1995) (7)
Digestion of the human blood-meal by the mosquito, Aedes aegypti. (1971) (7)
Teleost fish osteocalcin 1 and 2 share the ability to bind the calcium mineral phase (2014) (7)
Decreased coevolutionary potential and increased symbiont fecundity during the biological invasion of a legume‐rhizobium mutualism (2021) (7)
1,25-Dihydroxyvitamin D3 increases citrate secretion from osteosarcoma cells. (1984) (6)
Discovery of Surfactins as Inhibitors of MicroRNA Processing Using Cat-ELCCA. (2021) (6)
Analysis for gamma-carboxyglutamic acid. (1983) (6)
1 , 25-Dihydroxyvitamin D 3 Stimulates the Synthesis of Matrix y-Carboxyglutamic Acid Protein by Osteosarcoma Cells (2001) (6)
The vitamin K-dependent bone protein and the vitamin D-dependent biochemical response of bone to dietary calcium deficiency (1982) (5)
The dichotomy in the effects of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone γ-carboxyglutamic acid-containing protein in serum and bone in vitamin D-deficient rats (1987) (5)
YKL-40 expression in breast cancer (2005) (4)
Serum bone Gla Protein (BGP, Osteocalcin) in Infants : Values Positively Correlated with Human Milk Intake. (1992) (4)
Decarboxylation of γ-carboxyglutamic acid residues in proteins (1984) (4)
Retinoic acid increases matrix gla protein in rat plasma (1993) (4)
YKL-40 protein expression in cancer cells and macrophages in colorectal cancer (2005) (4)
Effect of sulfate on the activity and the kinetics of dexoyribonucleic acid degradation by porcine spleen deoxyribonuclease. (1974) (4)
Serum YKL-40 in risk assessment for colorectal cancer. A population based, prospective study of 4,987 subjects at risk of colorectal cancer (2008) (3)
A Method for Decarboxylation of y-Carboxyglutamic Acid in Proteins PROPERTIES OF THE DECARBOXYLATED y-CARBOXYGLLJTAMIC ACID PROTEIN FROM CALF BONE* (2002) (3)
Fluorescence and kinetic studies on the divalent metal ion induced conformational changes in DNase a. (1981) (3)
Human parotid alpha-amylase--a test of the error theory of aging. (1974) (3)
Identification of a New Antimicrobial, Desertomycin H, Utilizing a Modified Crowded Plate Technique (2021) (2)
Monoclonal antibody therapy against YKL-40 delays growth in glioblastoma xenografts (2007) (2)
Specific tritium labeling of γ-carboxyglutamic acid residues in proteins (1984) (2)
Chemistry and biology of mineralized tissues : proceedings of the Fourth International Conference on the Chemistry and Biology of Mineralized Tissues held in Coronado, California on February 5-9, 1992 (1992) (2)
Effect of warfarin on early rat tooth development (1991) (1)
Purification of matrix Gla protein and osteocalcin from the adriatic sturgeon (Acipencer naccarii), an Ancient bony fish with a cartilaginous endoskeleton (2008) (1)
Erratum: Isolation and molecular cloning of a novel bone phosphoprotein related in sequence to the cystatin family of thiol protease inhibitors (Journal of Biological Chemistry (1995) 270 (431-436)) (1995) (1)
Plasma vitamin K levels are associated with coronary calcification in older adults. (2006) (1)
Association of serum level of YKL-40 in patients with squamous cell carcinoma of the head and neck with survival. (2006) (1)
VITAMIN K-DEPENDENT CALCIUM BINDING PROTEINS OF THE EXTRACELLULAR BONE MATRIX (1987) (1)
YKL-40 expression in naevocellular naevi, carcinomas and melanomas of the skin. (2006) (1)
Serum YKL-40 in patients with inflammatory bowel disease (2001) (1)
INHIBITION OF 1,25-DIHYDROXYVITAMIN D3 STIMULATED BGP mRNA SYNTHESIS IN ROS 17/2 CELLS AFTER PROLONGED TREATMENT WITH 1,25- DIHYDROXYVITAMIN D3 (1988) (1)
Recommendations on nomenclature and standards for bone proteins and growth factors. (1986) (1)
Decarboxylation of gamma-carboxyglutamic acid residues in proteins. (1984) (1)
Monoclonal cle-40 antibody (2006) (0)
A high serum level of YKL-40 in patients with cervical cancer is associated with short survival (2007) (0)
Sturgeon Cartilage and Highly Conserved K-dependent Protein Identified from Gla-rich Protein ( GRP ) , A New Vitamin Modification , and Degradation : Protein Synthesis , Post-Translational (2008) (0)
Specific tritium labeling of gamma-carboxyglutamic acid residues in proteins. (1984) (0)
Teleost fish osteocalcin 1 and 2 share the ability to bind the calcium mineral phase (2013) (0)
DETECTION AND LOCALIZATION OF OSTEOCALCIN (BGP OR BONE GLA PROTEIN) IN TELEOSTS BY IN SITU HYBRIDATION AND IMMUNOHISTOCHEMISTRY (2001) (0)
OSTEOCALCIN FROM FISH ARGYROSOMUS REGIUS (2004) (0)
Primary structure ofthe-y-carboxyglutamic acid-containing protein frombovine bone (1976) (0)
Experiments on the Synergy Between Warfarin and Vitamin D in Artery Calcification (2000) (0)
Nomenclature recommendations: Bone proteins and growth factors. (1986) (0)
Subject Index Vol. 30, 2000 (2001) (0)
Variations in serum P1NP, BAP and YKL-40 levels after start of treatment for advanced prostate cancer and the relation to prognosis (2004) (0)
Anticorps monoclonaux ykl-40 (2006) (0)
Cle-40 as a marker and indicator for prognosis of cancer and detection of infections (1999) (0)
Nutrient Interactions and Toxicity The Amino Bisphosphonate Ibandronate Prevents Vitamin D Toxicity and Inhibits Vitamin D-Induced Calcification of Arteries , Cartilage , Lungs and Kidneys in Rats 1 (2001) (0)
The Vitamin K-Dependent Bone Protein and the Action of 1,25-Dihydroxyvitamin D3 on Bone (1985) (0)
Contents Vol. 30, 2000 (2001) (0)
YKL-40 expression in normal adult human tissue: an immunohistochemical study (2007) (0)
0377: Serum Ykl-40 Levels in Patients with Cervical Cancer Are Elevated Compared to Patients with Cervical Intraepithelial Neoplasia and Healthy Controls (2006) (0)
High serum YKL-40 level in patients with extended small cell lung cancer is related to short survival. (2004) (0)
High serum YKL-40 level in patients with extended small cell lung cancer is related to short survival (2004) (0)
Digestion of the avian blood-meal by the mosquito, Aedes aegypti. (1971) (0)
Radioimmunoassay for the vitamin ) its discovery in plasma ('y-carboxyglutamate/'y-carboxyglutamate-containing protein/calc: (2016) (0)
Variations in serum P1NP, BAP and YKL-40 levels after start of treatment for advanced prostate cancer and the relation to prognosis. (2004) (0)
Syddansk Universitet YKL-40 tissue expression and plasma levels in patients with ovarian cancer (2015) (0)
Detection of YKL-40 as a marker for degradation of bindegewebsmatrizen (1994) (0)
Warfarin and bone: implications for rational strategies to selectively antagonize the action of vitamin K in target tissues. (1987) (0)
PrognosticValue of PINP , BoneAlkaline Phosphatase , CTX-I , andYKL-40 in PatientsWithMetastatic ProstateCarcinoma (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paul A. Price?

Paul A. Price is affiliated with the following schools: